Skip to main content
Top
Published in: BMC Infectious Diseases 1/2006

Open Access 01-12-2006 | Research article

Seroepidemiology of Toxoplasma gondiiinfection in psychiatric inpatients in a northern Mexican city

Authors: Cosme Alvarado-Esquivel, Olga-Patricia Alanis-Quiñones, Miguel-Ángel Arreola-Valenzuela, Alfredo Rodríguez-Briones, Luis-Jorge Piedra-Nevarez, Ehecatl Duran-Morales, Sergio Estrada-Martínez, Sergio-Arturo Martínez-García, Oliver Liesenfeld

Published in: BMC Infectious Diseases | Issue 1/2006

Login to get access

Abstract

Background

Patients with psychiatric disorders were found to show a high seroprevalence of Toxoplasma gondii infection. There is scarce information about the epidemiology of T. gondii infection in psychiatric patients in Mexico. Therefore, we sought to determine the prevalence of T. gondii infection and associated socio-demographic, clinical and behavioural characteristics in a population of psychiatric patients in Durango City, Mexico. Seroprevalence in patients was compared with that obtained in a control population.

Methods

One hundred and thirty seven inpatients of a public psychiatric hospital and 180 controls were examined for the presence of IgG and IgM antibodies against T. gondii by enzyme-linked immunoassay (Diagnostic Automation Inc., Calabasas, CA, USA). The control population consisted of blood donors of a public blood bank and elderly persons attending a senior center in the same city. Age in controls (42 years +/- 20.2) was comparable with that of the psychiatric patients (43.7 years +/-13.8) (p = 0.42). Socio-demographic, clinical and behavioral characteristics from the patients were also obtained.

Results

Anti-T. gondii IgG antibodies indicating latent infection with T. gondii was found in 25 (18.2%) of 137 psychiatric inpatients and 16 (8.9%) of 180 controls (p = 0.02). Ten (26.3%) of 38 schizophrenic patients had latent infection and this prevalence was also significantly higher than that observed in controls (p = 0.005). Prevalence of anti-T. gondii IgM antibodies was comparable among patients and controls (4.4% vs 2.2%, respectively, p = 0.22). Multivariate analysis showed that T. gondii infection in inpatients was positively associated with sexual promiscuity (adjusted OR = 15.8; 95% CI: 3.8–64.8), unwashed raw fruit consumption (adjusted OR = 5.19; 95% CI: 2.3–11.3), and a history of surgery (adjusted OR = 6.5; 95% CI: 2.6–16), and negatively associated with lamb meat consumption (adjusted OR = 0.26; 95% CI: 0.10–0.63).

Conclusion

In the present study, psychiatric inpatients in Durango, Mexico, in general and schizophrenia inpatients in particular had a significantly higher prevalence of T. gondii infection than the control group. Results suggest that unwashed raw fruit consumption might be the most important route of T. gondii transmission in our psychiatric inpatients while lamb meat consumption the less important. Additional studies will have to elucidate the causative relation between infection with T. gondii and psychiatric disorders.
Literature
1.
go back to reference Alvarado-Esquivel C, Sifuentes-Alvarez A, Narro-Duarte SG, Estrada-Martinez S, Diaz-Garcia JH, Liesenfeld O, Martinez-Garcia SA, Canales-Molina A: Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico. BMC Infect Dis. 6: 113-10.1186/1471-2334-6-113. 2006 Jul 13 Alvarado-Esquivel C, Sifuentes-Alvarez A, Narro-Duarte SG, Estrada-Martinez S, Diaz-Garcia JH, Liesenfeld O, Martinez-Garcia SA, Canales-Molina A: Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico. BMC Infect Dis. 6: 113-10.1186/1471-2334-6-113. 2006 Jul 13
2.
go back to reference Hill DE, Chirukandoth S, Dubey JP: Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev. 2005, 6: 41-61. 10.1079/AHR2005100.CrossRefPubMed Hill DE, Chirukandoth S, Dubey JP: Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev. 2005, 6: 41-61. 10.1079/AHR2005100.CrossRefPubMed
3.
go back to reference Montoya JG, Liesenfeld O: Toxoplasmosis. Lancet. 2004, 363: 1965-1976. 10.1016/S0140-6736(04)16412-X.CrossRefPubMed Montoya JG, Liesenfeld O: Toxoplasmosis. Lancet. 2004, 363: 1965-1976. 10.1016/S0140-6736(04)16412-X.CrossRefPubMed
4.
go back to reference Dubey JP: Toxoplasmosis – a waterborne zoonosis. Vet Parasitol. 2004, 126: 57-72. 10.1016/j.vetpar.2004.09.005.CrossRefPubMed Dubey JP: Toxoplasmosis – a waterborne zoonosis. Vet Parasitol. 2004, 126: 57-72. 10.1016/j.vetpar.2004.09.005.CrossRefPubMed
5.
go back to reference Dawson D: Foodborne protozoan parasites. Int J Food Microbiol. 2005, 103: 207-227. 10.1016/j.ijfoodmicro.2004.12.032.CrossRefPubMed Dawson D: Foodborne protozoan parasites. Int J Food Microbiol. 2005, 103: 207-227. 10.1016/j.ijfoodmicro.2004.12.032.CrossRefPubMed
6.
go back to reference Kravetz JD, Federman DG: Toxoplasmosis in pregnancy. Am J Med. 2005, 118: 212-216. 10.1016/j.amjmed.2004.08.023.CrossRefPubMed Kravetz JD, Federman DG: Toxoplasmosis in pregnancy. Am J Med. 2005, 118: 212-216. 10.1016/j.amjmed.2004.08.023.CrossRefPubMed
7.
go back to reference Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R: Congenital toxoplasmosis: a review. Obstet Gynecol Surv. 2001, 56: 296-305. 10.1097/00006254-200105000-00025.CrossRefPubMed Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R: Congenital toxoplasmosis: a review. Obstet Gynecol Surv. 2001, 56: 296-305. 10.1097/00006254-200105000-00025.CrossRefPubMed
8.
go back to reference Bossi P, Caumes E, Paris L, Darde ML, Bricaire F: Toxoplasma gondii-associated Guillain-Barre syndrome in an immunocompetent patient. J Clin Microbiol. 1998, 36: 3724-5.PubMedPubMedCentral Bossi P, Caumes E, Paris L, Darde ML, Bricaire F: Toxoplasma gondii-associated Guillain-Barre syndrome in an immunocompetent patient. J Clin Microbiol. 1998, 36: 3724-5.PubMedPubMedCentral
9.
go back to reference Silva LA, Vieira RS, Serafini LN, Carlotti CG, Figueiredo JF: Toxoplasmosis of the central nervous system in a patient without immunosupression: case report. Rev Soc Bras Med Trop. 2001, 34: 487-90.PubMed Silva LA, Vieira RS, Serafini LN, Carlotti CG, Figueiredo JF: Toxoplasmosis of the central nervous system in a patient without immunosupression: case report. Rev Soc Bras Med Trop. 2001, 34: 487-90.PubMed
10.
go back to reference Kramer W: Frontiers of neurological diagnosis in acquired toxoplasmosis. Psychiatr Neurol Neurochir. 1966, 69: 43-64.PubMed Kramer W: Frontiers of neurological diagnosis in acquired toxoplasmosis. Psychiatr Neurol Neurochir. 1966, 69: 43-64.PubMed
11.
go back to reference Yolken RH, Bachmann S, Rouslanova I, Lillehoj E, Ford G, Torrey F, Schroeder J: Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clinical Infectious Diseases. 2001, 32: 842-4. 10.1086/319221.CrossRefPubMed Yolken RH, Bachmann S, Rouslanova I, Lillehoj E, Ford G, Torrey F, Schroeder J: Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clinical Infectious Diseases. 2001, 32: 842-4. 10.1086/319221.CrossRefPubMed
13.
go back to reference Bronfman M, Guiscafré H, Castro V, Castro R, Gutiérrez G: La medición de la desigualdad: una estrategia metodológica, análisis de las características socioeconómicas de la muestra. Arch Invest Med. 1988, 19: 351-360. Bronfman M, Guiscafré H, Castro V, Castro R, Gutiérrez G: La medición de la desigualdad: una estrategia metodológica, análisis de las características socioeconómicas de la muestra. Arch Invest Med. 1988, 19: 351-360.
14.
go back to reference Clasificación Estadística Internacional de Enfermedades y Problemas relacionados con la Salud. Organización Panamericana de la Salud. Washington, USA. 1995, 1–3: 10 Clasificación Estadística Internacional de Enfermedades y Problemas relacionados con la Salud. Organización Panamericana de la Salud. Washington, USA. 1995, 1–3: 10
15.
go back to reference Buentello E: Comunicación preliminary sobre las relaciones entre toxoplasmosis, acido lisergico y esquizofrenia. Gac Med Mex. 1958, 88: 693-708.PubMed Buentello E: Comunicación preliminary sobre las relaciones entre toxoplasmosis, acido lisergico y esquizofrenia. Gac Med Mex. 1958, 88: 693-708.PubMed
16.
go back to reference Delgado García G: Toxoplasmosis and mental diseases. Rev Cubana Med Trop. 1979, 31: 127-131.PubMed Delgado García G: Toxoplasmosis and mental diseases. Rev Cubana Med Trop. 1979, 31: 127-131.PubMed
17.
go back to reference Delgado Garcia G, Garcia Landa J: Reactivity of the intradermal test with toxoplasmosis in schizophrenic patients. Rev Cubana Med Trop. 1979, 31: 225-231.PubMed Delgado Garcia G, Garcia Landa J: Reactivity of the intradermal test with toxoplasmosis in schizophrenic patients. Rev Cubana Med Trop. 1979, 31: 225-231.PubMed
18.
go back to reference Yolken RH, Bachmann S, Ruslanova I, Lillehoj E, Ford G, Torrey EF, Schroeder J: Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infect Dis. 2001, 32: 842-844. 10.1086/319221.CrossRefPubMed Yolken RH, Bachmann S, Ruslanova I, Lillehoj E, Ford G, Torrey EF, Schroeder J: Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infect Dis. 2001, 32: 842-844. 10.1086/319221.CrossRefPubMed
19.
go back to reference Wang HL, Wang GH, Li QY, Shu C, Jiang MS, Guo Y: Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr Scand. 2001, 114: 40-48. 10.1111/j.1600-0447.2006.00780.x.CrossRef Wang HL, Wang GH, Li QY, Shu C, Jiang MS, Guo Y: Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr Scand. 2001, 114: 40-48. 10.1111/j.1600-0447.2006.00780.x.CrossRef
20.
go back to reference Roch E, Varela G: Diversos aspectos de la investigación sobre toxoplasmosis en México. Resultados obtenidos en 29 883 reacciones de Sabin y Feldman efectuadas de 1953 a 1965. Rev Invest Salud Publ (Mex). 1966, 26: 31-49. Roch E, Varela G: Diversos aspectos de la investigación sobre toxoplasmosis en México. Resultados obtenidos en 29 883 reacciones de Sabin y Feldman efectuadas de 1953 a 1965. Rev Invest Salud Publ (Mex). 1966, 26: 31-49.
21.
go back to reference Janitschke K, Nurnberger F: Studies on the significance of sexual intercourse for the transmission of Toxoplasma gondii. Zentralbl Bakteriol [Orig A]. 1975, 231: 323-332. Janitschke K, Nurnberger F: Studies on the significance of sexual intercourse for the transmission of Toxoplasma gondii. Zentralbl Bakteriol [Orig A]. 1975, 231: 323-332.
22.
go back to reference Martinez-Garcia F, Regadera J, Mayer R, Sanchez S, Nistal M: Protozoan infections in the male genital tract. J Urol. 1996, 156: 340-349. 10.1016/S0022-5347(01)65846-4.CrossRefPubMed Martinez-Garcia F, Regadera J, Mayer R, Sanchez S, Nistal M: Protozoan infections in the male genital tract. J Urol. 1996, 156: 340-349. 10.1016/S0022-5347(01)65846-4.CrossRefPubMed
23.
go back to reference Berdoy M, Webster JP, Macdonald DW: Parasite-altered behaviour: is the effect of Toxoplasma gondii on Rattus norvegicus specific?. Parasitology. 1995, 111: 403-409.CrossRefPubMed Berdoy M, Webster JP, Macdonald DW: Parasite-altered behaviour: is the effect of Toxoplasma gondii on Rattus norvegicus specific?. Parasitology. 1995, 111: 403-409.CrossRefPubMed
24.
go back to reference Webster JP, Brunton CF, MacDonald DW: Effect of Toxoplasma gondii upon neophobic behaviour in wild brown rats, Rattus norvegicus. Parasitology. 1994, 109: 37-43.CrossRefPubMed Webster JP, Brunton CF, MacDonald DW: Effect of Toxoplasma gondii upon neophobic behaviour in wild brown rats, Rattus norvegicus. Parasitology. 1994, 109: 37-43.CrossRefPubMed
25.
go back to reference Baril L, Ancelle T, Goulet V, Thulliez P, Tirard-Fleury V, Carme B: Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand J Infect Dis. 1999, 31: 305-309. 10.1080/00365549950163626.CrossRefPubMed Baril L, Ancelle T, Goulet V, Thulliez P, Tirard-Fleury V, Carme B: Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand J Infect Dis. 1999, 31: 305-309. 10.1080/00365549950163626.CrossRefPubMed
26.
go back to reference Ertug S, Okyay P, Turkmen M, Yuksel H: Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health. 2005, 5: 66-10.1186/1471-2458-5-66.CrossRefPubMedPubMedCentral Ertug S, Okyay P, Turkmen M, Yuksel H: Seroprevalence and risk factors for toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health. 2005, 5: 66-10.1186/1471-2458-5-66.CrossRefPubMedPubMedCentral
27.
go back to reference Lopez-Castillo CA, Diaz-Ramirez J, Gomez-Marin JE: Risk factors for Toxoplasma gondii infection in pregnant women in Armenia, Colombia. Rev Salud Publica. 2005, 7: 180-190.CrossRefPubMed Lopez-Castillo CA, Diaz-Ramirez J, Gomez-Marin JE: Risk factors for Toxoplasma gondii infection in pregnant women in Armenia, Colombia. Rev Salud Publica. 2005, 7: 180-190.CrossRefPubMed
28.
go back to reference de Moura L, Bahia-Oliveira LM, Wada MY, Jones JL, Tuboi SH, Carmo EH, Ramalho WM, Camargo NJ, Trevisan R, Graca RM, da Silva AJ, Moura I, Dubey JP, Garrett DO: Waterborne toxoplasmosis, Brazil, from field to gene. Emerg Infect Dis. 2006, 12: 326-9.CrossRefPubMedPubMedCentral de Moura L, Bahia-Oliveira LM, Wada MY, Jones JL, Tuboi SH, Carmo EH, Ramalho WM, Camargo NJ, Trevisan R, Graca RM, da Silva AJ, Moura I, Dubey JP, Garrett DO: Waterborne toxoplasmosis, Brazil, from field to gene. Emerg Infect Dis. 2006, 12: 326-9.CrossRefPubMedPubMedCentral
29.
go back to reference Spalding SM, Amendoeira MR, Klein CH, Ribeiro LC: Serological screening and toxoplasmosis exposure factors among pregnant women in South of Brazil. Rev Soc Bras Med Trop. 2005, 38: 173-177. 10.1590/S0037-86822005000200009.CrossRefPubMed Spalding SM, Amendoeira MR, Klein CH, Ribeiro LC: Serological screening and toxoplasmosis exposure factors among pregnant women in South of Brazil. Rev Soc Bras Med Trop. 2005, 38: 173-177. 10.1590/S0037-86822005000200009.CrossRefPubMed
30.
go back to reference Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, Foulon W, Semprini AE, Dunn DT: Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ. 2000, 321: 142-147. 10.1136/bmj.321.7254.142.CrossRefPubMedPubMedCentral Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, Foulon W, Semprini AE, Dunn DT: Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ. 2000, 321: 142-147. 10.1136/bmj.321.7254.142.CrossRefPubMedPubMedCentral
Metadata
Title
Seroepidemiology of Toxoplasma gondiiinfection in psychiatric inpatients in a northern Mexican city
Authors
Cosme Alvarado-Esquivel
Olga-Patricia Alanis-Quiñones
Miguel-Ángel Arreola-Valenzuela
Alfredo Rodríguez-Briones
Luis-Jorge Piedra-Nevarez
Ehecatl Duran-Morales
Sergio Estrada-Martínez
Sergio-Arturo Martínez-García
Oliver Liesenfeld
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2006
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-6-178

Other articles of this Issue 1/2006

BMC Infectious Diseases 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.